Nonpharmacological therapies for atrial fibrillation

Cardiovascular Therapeutics

Volumn 28, Issue 5, 2010, Pages 264-277

  Meshil, Mark Alber ^a   Bhakta, Deepak ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ablation; Atrial fibrillation; maze procedure; pacemaker; pulmonary vein isolation

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; REVIEW;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CARDIAC SURGICAL PROCEDURES; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HEART RATE; HUMANS; PACEMAKER, ARTIFICIAL; RECURRENCE; TREATMENT OUTCOME;

EID: 77956414118     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2010.00199.x     Document Type: Review

References (136)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention; the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. J Am Med Assoc 2001 285 : 2370 2375.
2. Benjamin EJ, Levy DL, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort; the Framingham heart study. J Am Med Assoc 1994 271 : 840 884.
3. Feinberg W, Blackshear J, Laupacis A, Kronmal R, Hart R. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995 155 : 469 473.
4. Rubart M, Zipes DP. Genesis of cardiac arrhythmias: Electrophysiologic consideration. In: Zipes DP, Libby P, Bonow R, Braunwald E, editors. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th edition, Philadelphia: WB Saunders Company, 2005 653 687.
5. Chen S, Hseih M, Tai C, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiologic characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999 100 : 1879 1886.
6. Oral H, Ozaydin M, Tada H, et al. Mechanistic significance of intermittent pulmonary vein tachycardia in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2002 13 : 645 650. (Pubitemid 34774898)
7. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002 347 : 1825 1833.
8. Steinberg JS, Sadaniantz A, Kron J, et al. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004 109 : 1973 1980.
9. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002 347 : 1834 1840.
10. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation; Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomized trial. Lancet 2000 356 : 1789 1794.
11. Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003 41 : 1690 1696.
12. Opolski G, Torbicki A, Kosior DA, Szulc M, Wozakowska-Kaplon B, Kolodziej P, Achremczyk P. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: The results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004 126 : 476 486.
13. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial (CAST). N Engl J Med 1991 324 : 781 788.
14. Hohnloser SH, Meinertz T, Stubbs P, Crijns HJ, Blanc JJ, Rizzon P, Cheuvart B. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group. Circulation 1995 92 : 1517 1525.
15. Podrid PJ, Anderson JL, et al. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group. Am J Cardiol 1996 78 : 430 434.
16. Sodermark T, Jonsson B, Olsson A, et al. Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm. Br Heart J 1975 37 : 486 492.
17. Lloyd EA, Gersh BJ, Forman R. The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo. S Afr Med J 1984 65 : 367 369.
18. Stafford RS, Robson DC, Misra B, Ruskin J, Singer DE. Rate control and sinus rhythm maintenance in atrial fibrillation: National trends in medication use, 1980-1996. Arch Intern Med 1998 158 : 2144 2148.
19. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990 82 : 1106 1116.
20. Reimold SC, Chalmers TC, Berlin JA, Antman EM. Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: Observations on the role of trial design and implications of drug-related mortality. Am Heart J 1992 124 : 924 932.
21. Gallik DM, Kim SG, Ferrick KJ, Roth JA, Fisher JD. Efficacy and safety of sotalol in patients with refractory atrial fibrillation or flutter. Am Heart J 1997 134 : 155 160.
22. Alt E, Ammer R, Lehmann G, Putter K, Ayers GM, Pasquantonio J, Schomig A. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am Heart J 1997 134 : 419 425.
23. Benditt DG, Williams JH, Jin J, et al. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. Am J Cardiol 1999 84 : 270 277.
24. Pollak A, Falk RH. Aggravation of postcardioversion atrial dysfunction by sotalol. J Am Coll Cardiol 1995 25 : 665 671.
25. Karlson BW, Torstensson I, Abjorn C, Jansson SO, Peterson LE. Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study. Eur Heart J 1988 9 : 284 290.
26. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000 342 : 913 920.
27. Singh BN, Singh SN, Reda DJ, et al. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005 352 : 1861 1872.
28. Kochiadakis GE, Igoumenidis NE, Marketou ME, Kaleboubas MD, Simantirakis EN, Vardas PE. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: A comparative, placebo controlled study. Heart 2000 84 : 251 257.
29. The AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol 2003 42 : 20 29.
30. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med 2007 356 : 935 941.
31. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000 342 : 913 920.
32. Touboul P, Brugada J, Capucci A, Crijns HJ, Edvardsson N, Hohnloser SH. Dronedarone for prevention of atrial fibrillation: A dose-ranging study. Eur Heart J 2003 24 : 1481 1487.
33. Kathofer S, Thomas D, Karle CA. The novel antiarrhythmic drug dronedarone: Comparison with amiodarone. Cardiovasc Drug Rev 2005 23 : 217 230.
34. Singh BN, Connolly SJ, Crijns HJ, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007 357 : 987 999.
35. Kober L, Torp-Pedersen C, McMurray JJ, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008 358 : 2678 2687.
36. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009 360 : 668 678.
37. Roy D, Pratt CM, Torp-Pedersen C, et al. Atrial Arrhythmia Conversion Trial Investigators. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: A phase 3, randomized, placebo-controlled trial. Circulation 2008 117 : 1518 1525.
38. Conway E, Musco S, Kowey PR. New horizons in antiarrhythmic therapy: Will novel agents overcome current deficits? Am J Cardiol 2008 102 : 12H 19H.
39. Morady F. Radio-frequency ablation as treatment for cardiac arrhythmias. N Engl J Med 1999 340 : 534 544.
40. Zipes DP, DiMarco JP, Gillette PC, et al. Guidelines for Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). Developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1995 26 : 555 573.
41. Ruffy R, Imran MA, Santel DJ, Wharton JM. Radiofrequency delivery through a cooled catheter tip allows the creation of larger endomyocardial lesions in the ovine heart. J Cardiovasc Electrophysiol 1995 6 : 1089 1096.
42. Dinerman JL, Berger RD, Calkins H. Temperature monitoring during radiofrequency ablation. J Cardiovasc Electrophysiol 1996 7 : 163 173.
43. Jais P, Shah DC, Haissaguerre M, Hocini M, Garrigue S, Le Metayer P, Clementy J. Prospective randomized comparison of irrigated-tip versus conventional-tip catheters for ablation of common flutter. Circulation 2000 101 : 772 776.
44. Yamane T, Jais P, Shah DC, Hocini M, Peng JT, Deisenhofer I, Clementy J, Haissaguerre M. Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation. Circulation 2000 102 : 2565 2568.
45. Calkins H, Epstein A, Packer D, et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: Results of a prospective multicenter study. Cooled RF Multi Center Investigators Group. J Am Coll Cardiol 2000 35 : 1905 1914.
46. Soejima K, Delacretaz E, Suzuki M, Brunckhorst CB, Maisel WH, Friedman PL, Stevenson WG. Saline-cooled versus standard radiofrequency catheter ablation for infarct-related ventricular tachycardias. Circulation 2001 103 : 1858 1862.
47. Valles E, Fan R, Roux JF, et al. Localization of atrial fibrillation triggers in patients undergoing pulmonary vein isolation: Importance of the carina region. J Am Coll Cardiol 2008 52 : 1413 1420.
48. Saad EB, Marrouche NF, Saad CP, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation: Emergence of a new clinical syndrome. Ann Intern Med 2003 138 : 634 638.
49. Cappato R, Calkins H, Chen SA, et al. Up-dated worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophys 2010 3 : 32 38.
50. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: A meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009 2 : 626 633.
51. Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation: Segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003 108 : 2355 2360. (Pubitemid 37413542)
52. Pappone C, Santinelli V, Manguso F, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004 109 : 327 334.
53. Lin WS, Tai CT, Hsieh MH, et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 2003 107 : 3176 3183.
54. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: Mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004 43 : 2044 2053.
55. Karch MR, Zrenner B, Deisenhofer I, et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: A randomized comparison between 2 current ablation strategies. Circulation 2005 111 : 2875 2880.
56. Pappone C, Oral H, Santinelli V, et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004 109 : 2724 2726.
57. Scanavacca MI, D'avila A, Parga J, Sosa E. Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2004 15 : 960 962.
58. Shah D, Dumonceau JM, Burri H, et al. Acute pyloric spasm and gastric hypomotility: An extracardiac adverse effect of percutaneous radiofrequency ablation for atrial fibrillation. J Am Coll Cardiol 2005 46 : 327 330.
59. Lin JL, Lai LP, Tseng YZ, Lien WP, Huang SK. Global distribution of atrial ectopic foci triggering recurrence of atrial tachyarrhythmia after electrical cardioversion of long-standing atrial fibrillation: A bi-atrial basket mapping study. J Am Coll Cardiol 2001 37 : 904 910.
60. Cheema A, Dong J, Dalal D, et al. Circumferential ablation with pulmonary vein isolation in permanent atrial fibrillation. Am J Cardiol 2007 99 : 1425 1428.
61. Jens E, Sander V, Natasja de G, Maurits A, Ulrich S. Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria. Prog Biophys Mol Biol 2008 97 : 435 451.
62. Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006 354 : 934 941.
63. Sanders P, Hocini M, Jais P, et al. Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation. Long-term clinical outcome. Eur Heart J 2007 28 : 1862 1871.
64. Konings KT, Smeets JL, Penn OC, Wellens HJ, Allessie MA. Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans. Circulation 1997 95 : 1231 1241.
65. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: Mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004 43 : 2044 2053.
66. Oral H, Chugh A, Good E, et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation 2007 115 : 2606 2612.
67. Nademanee K, Schwab MC, Kosar EM, et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 2008 51 : 843 849.
68. Hou Y, Scherlag BJ, Lin J, et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: Effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol 2007 50 : 61 68.
69. Schauerte P, Scherlag BJ, Pitha J, Scherlag MA, Reynolds D, Lazzara R, Jackman WM. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation 2000 102 : 2774 2780.
70. Scanavacca M, Pisani CF, Hachul D, et al. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation. Circulation 2006 114 : 876 885.
71. Oral H, Knight BP, Ozaydin M, et al. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 2002 40 : 100 104. (Pubitemid 34701383)
72. Berruezo A, Tamborero D, Mont L, et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 2007 28 : 836 841.
73. Chen SA, Tai CT. Catheter ablation of atrial fibrillation originating from the non-pulmonary vein foci. J Cardiovasc Electrophysiol 2005 16 : 229 232.
74. Lee SH, Tai CT, Hsieh MH, et al. Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: Implication for catheter ablation. J Am Coll Cardiol 2005 46 : 1054 1059.
75. Haissaguerre M, Hocini M, Sanders P, et al. Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation 2006 113 : 616 625.
76. Verma A, Wazni OM, Marrouche NF, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: An independent predictor of procedural failure. J Am Coll Cardiol 2005 45 : 285 292.
77. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007 4 : 816 861.
78. Chugh A, Oral H, Good E, et al. Catheter ablation of atypical atrial flutter and atrial tachycardia within the coronary sinus after left atrial ablation for atrial fibrillation. J Am Coll Cardiol 2005 46 : 83 91.
79. Cummings JE, Schweikert R, Saliba W, et al. Left atrial flutter following pulmonary vein antrum isolation with radiofrequency energy: Linear lesions or repeat isolation. J Cardiovasc Electrophysiol 2005 16 : 293 297. (Pubitemid 40404595)
80. Rosenquvist M, Lee MA, Moulinier L, et al. Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol 1990 16 : 1467 1474.
81. Curtis AB, Kutalek SP, Prior M, Newhouse TT. Prevalence and characteristics of escape rhythms after radiofrequency ablation of the atrioventricular junction: Results from the registry for AV junction ablation and pacing in atrial fibrillation. Ablate and Pace Trial Investigators. Am Heart J 2000 139 (1 Pt 1 122 125.
82. Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 2000 23 : 1020 1028.
83. NealKay G, Ellenbogen KA, Michael G, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B. The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation. J Intervent Cardiac Electrophys 1998 2 : 121 135.
84. Fitzpatrick AP, Kourouyan HD, Siu A, et al. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: Impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 1996 131 : 499 507.
85. Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: A meta-analysis. Wood MA Circulation 2000 101 : 1138 1144.
86. Brown CS, Mills RM Jr., Conti JB, Curtis AB. Clinical improvement after atrioventricular nodal ablation for atrial fibrillation does not correlate with improved ejection fraction. Am J Cardiol 1997 80 : 1090 1091.
87. Weerasooriya R, Davis M, Powell A, et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol 2003 41 : 1697 1702.
88. Ozcan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001 344 : 1043 1051.
89. Ozcan C, Jahangir A, Friedman PA, et al. Sudden death after radiofrequency ablation of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 2002 40 : 105 110.
90. Hamdan MH, Page RL, Sheehan CJ, et al. Increased sympathetic activity after atrioventricular junction ablation in patients with chronic atrial fibrillation. J Am Coll Cardiol 2000 36 : 151 158.
91. Williamson BD, Man KC, Daoud E, Niebauer M, Strickberger SA, Morady F. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994 331 : 910 917.
92. Canby RC, Roman CA, Kessler DJ, Horton RP, Page RL. Selective radiofrequency ablation of the "slow" atrioventricular nodal pathway for control of the ventricular response to atrial fibrillation. Am J Cardiol 1996 77 : 1358 1361.
93. Della BP, Carbucicchio C, Tondo C, Riva S. Modulation of atrioventricular conduction by ablation of the "slow" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter. J Am Coll Cardiol 1995 25 : 39 46.
94. Kreiner G, Heinz G, Siostrzonek P, Gossinger HD. Effect of slow pathway ablation on ventricular rate during atrial fibrillation. Dependence on electrophysiological properties of the fast pathway. Circulation 1996 93 : 277 283.
95. Strickberger SA, Weiss R, Daoud EG, Goyal R, Bogun F, Man KC, Morady F. Ventricular rate during atrial fibrillation before and after slow-pathway ablation. Effects of autonomic blockade and beta-adrenergic stimulation. Circulation 1996 94 : 1023 1026.
96. Twidale N, McDonald T, Nave K, Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol 1998 21 (4 Pt 1 641 651.
97. Proclemer A, Della Bella P, Tondo C, Facchin D, Carbucicchio C, Riva S, Fioretti P. Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation. Am J Cardiol 1999 83 : 1437 1442.
98. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) J Am Coll Cardiol 2006 48 : e149 246.
99. Gasparini M, Mantica M, Brignole M, et al. Thromboembolism after atrioventricular node ablation and pacing: Long term follow up. Heart 1999 82 : 494 498.
100. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991 101 : 406 426.
101. Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg 1991 101 : 584 592.
102. Cox JL, Boineau JP, Schuessler RB, et al. Electrophysiologic basis, surgical development, and clinical results of the maze procedure for atrial flutter and atrial fibrillation. Adv Card Surg 1995 6 : 1 67.
103. Cox JL, Boineau JP, Schuessler RB, Kater KM, Lappas DG. Five-year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 1993 56 : 814 823 discussion 823 824.
104. Kosakai Y, Kawaguchi AT, Isobe F, et al. Modified maze procedure for patients with atrial fibrillation undergoing simultaneous open heart surgery. Circulation 1995 92 (9 Suppl II359 364.
105. Lonnerholm S, Blomstrom P, Nilsson L, Oxelbark S, Jideus L, Blomstrom-Lundqvist C. Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation 2000 101 : 2607 2611.
106. Cox JL, Jaquiss RD, Schuessler RB, Boineau JP. Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure. J Thorac Cardiovasc Surg 1995 110 : 485 495.
107. Pasic M, Musci M, Siniawski H, et al. The Cox maze iii procedure: Parallel normalization of sinus node dysfunction, improvement of atrial function, and recovery of the cardiac autonomic nervous system. J Thorac Cardiovasc Surg 1999 118 : 287 295.
108. Pasic M, Musci M, Siniawski H, Edelmann B, Tedoriya T, Hetzer R. Transient sinus node dysfunction after the Cox-maze III procedure in patients with organic heart disease and chronic fixed atrial fibrillation. J Am Coll Cardiol 1998 32 : 1040 1047.
109. Izumoto H, Kawazoe K, Kitahara H, Kamata. Operative results after the Cox/maze procedure combined with a mitral valve operation. J Ann Thorac Surg 1998 66 : 800 804.
110. Nitta T, Lee R, Watanabe H, et al. Radial approach: A new concept in surgical treatment for atrial fibrillation II. Electrophysiologic effects and atrial contribution to ventricular filling. Ann Thorac Surg 1999 67 : 36 50. (Pubitemid 29138729)
111. Nitta T, Lee R, Schuessler RB, Boineau JP, Cox JL. Radial approach: A new concept in surgical treatment for atrial fibrillation I. Concept, anatomic and physiologic bases and development of a procedure. Ann Thorac Surg 1999 67 : 27 35.
112. Nitta T, Ishii Y, Ogasawara H, et al. Initial experience with the radial incision approach for atrial fibrillation. Ann Thorac Surg 1999 68 : 805 810 discussion 811.
113. Sueda T, Imai K, Ishii O, Orihashi K, Watari M, Okada K. Efficacy of pulmonary vein isolation for the elimination of chronic atrial fibrillation in cardiac valvular surgery. Ann Thorac Surg 2001 71 : 1189 1193.
114. de Lima GG, Kalil RA, Leiria TL, et al. Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease. Ann Thorac Surg 2004 77 : 2089 2094 discussion 2094 2095.
115. Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: A meta-analysis. J Thorac Cardiovasc Surg 2006 131 : 1029 1035.
116. Mantovan R, Raviele A, Buja G, et al. Left atrial radiofrequency ablation during cardiac surgery in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2003 14 : 1289 1295.
117. Kottkamp H, Hindricks G, Autschbach R, et al. Specific linear left atrial lesions in atrial fibrillation: Intraoperative radiofrequency ablation using minimally invasive surgical techniques. J Am Coll Cardiol 2002 40 : 475 480.
118. Melby SJ, Zierer A, Bailey MS, et al. A new era in the surgical treatment of atrial fibrillation: The impact of ablation technology and lesion set on procedural efficacy. Ann Surg 2006 244 : 583 592.
119. van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA 2002 288 : 2441 2448.
120. Hart RG, Pearce LA, Koudstaal PJ. Transient ischemic attacks in patients with atrial fibrillation: Implications for secondary prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial. Stroke 2004 35 : 948 951.
121. Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg 1999 118 : 833 840.
122. AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation (ABLATE Permanent) clinical trial. Sponsored by AtriCure, Inc., December. Clinical Trials Gov Identifier: NCT00560885.
123. AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB (RESTORE SR IIB). Sponsored by AtriCure, Inc., August 2009. Clinical Trials Gov Identifier: NCT00571779.
124. Cooper JM, Katcher MS, Orlov MV. Implantable devices for the treatment of atrial fibrillation. N Engl J Med 2002 346 : 2062 2068.
125. Delfaut P, Saksena S, Prakash A, Krol RB. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 1998 32 : 1900 1908.
126. Levy T, Walker S, Rex S, Rochelle J, Paul V. No incremental benefit of multisite atrial pacing compared with right atrial pacing in patients with drug refractory paroxysmal atrial fibrillation. Heart 2001 85 : 48 52.
127. Lau CP, Tse HF, Yu CM, et al. Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. Am J Cardiol 2001 88 : 371 375.
128. Leclercq JF, De Sisti A, Fiorello P, Halimi F, Manot S, Attuel P. Is dual site better than single site atrial pacing in the prevention of atrial fibrillation Pacing Clin Electrophysiol 2000 23 : 2101 2107.
129. Saksena S, Prakash A, Ziegler P, et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002 40 : 1140 1150 discussion 1151 1152.
130. Carlson MD, Ip J, Messenger J, et al. A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003 42 : 627 633.
131. Murgatroyd FD, Slade AK, Sopher SM, Rowland E, Ward DE, Camm AJ. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995 25 : 1347 1353.
132. Alt E, Schmitt C, Ammer R, Coenen M, Fotuhi P, Karch M, Blasini R. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol 1994 17 (5 Pt 2 1067 1078.
133. Levy S, Ricard P, Lau CP, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997 29 : 750 755.
134. Levy S, Ricard P, Gueunoun M, Yapo F, Trigano J, Mansouri C, Paganelli F. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results. Circulation 1997 96 : 253 259. (Pubitemid 27298429)
135. Saksena S, Prakash A, Mangeon L, et al. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol 1995 76 : 913 921.
136. Ayers GM, Alferness CA, Ilina M, Wagner DO, Sirokman WA, Adams JM, Griffin JC. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation 1994 89 : 413 422.